1 - 5 of 5 results (0.82 seconds)
Sort By:
  • Pharmacoeconomics: Why ShouldActuaries Care?
    the Medical Device Industry by Robert McCarthy 17 Comparison of Risk Adjusters by Bob Cumming 19 ... this case. The total decision tree has 17 nodes in it for 17 different drug treatments. Figures 1 and ...

    View Description

    • Authors: Jill Van Den Bos
    • Date: Oct 2002
    • Competency: External Forces & Industry Knowledge>Actuarial methods in business operations
    • Publication Name: Health Watch
    • Topics: Economics>Health economics
  • The Formulary Decision Process:What Are They Doing in There and Can Actuaries Help?
    pharmaceutical benefit trends have increased at rates of 17 percent to 18 percent.ii These pharmaceutical cost ... 2002-2003. Available at www.amcp.org. Accessed February 17, 2004. xvi Neumann, P. Evidence-based and value-based ...

    View Description

    • Authors: Jonathan L Shreve, Jill Van Den Bos, John Watkins, Kristin Reed
    • Date: Mar 2005
    • Competency: Technical Skills & Analytical Problem Solving>Process and technique refinement
    • Publication Name: Health Watch
    • Topics: Health & Disability>Health care
  • Globalization of the Pharmaceutical Supply Chain: What are the Risks? The FDA’s Difficult Task
    Globalization of the Pharmaceutical Supply Chain: What are the Risks? The FDA’s Difficult Task This ... Lipid-Lowering. annals of Internal medicine, Feb 17, 2009, 150(4):243-254. ContInUED on page 26 26 ...

    View Description

    • Authors: Jill Van Den Bos
    • Date: May 2009
    • Competency: External Forces & Industry Knowledge; Professional Values>Public interest representation; Strategic Insight and Integration>Strategy development; Technical Skills & Analytical Problem Solving>Incorporate risk management
    • Publication Name: Health Watch
    • Topics: Health & Disability>Health care quality; Public Policy; Technology & Applications
  • Health Section, Issue No. 44, October 2002 Health Section News newsletter
    the Medical Device Industry by Robert McCarthy 17 Comparison of Risk Adjusters by Bob Cumming 19 ... this case. The total decision tree has 17 nodes in it for 17 different drug treatments. Figures 1 and ...

    View Description

    • Authors: Daniel Wolak, Robert Cumming, Steven J Gaspar, Brian Small, Rowen Bell, Jill Van Den Bos, ROBERT FREDERICK MCCARTHY
    • Date: Oct 2002
    • Publication Name: Health Watch
  • Health Section News
    pharmaceutical benefit trends have increased at rates of 17 percent to 18 percent.ii These pharmaceutical cost ... care costs HEALTH SECTION NEWS | MARCH 2005 | 17 SMI parity designates parity for severe mental illnesses ...

    View Description

    • Authors: William Lane, Stephen P Melek, Jonathan L Shreve, Karl Volkmar, Dennis Hare, Corey Berger, Jill Van Den Bos, John Watkins
    • Date: Mar 2005
    • Publication Name: Health Watch